Amanote Research
Register
Sign In
P2.13-34 Long Intergenic Non-Coding RNA 00665 Induces Acquired Resistance to Gefitinib in Non-Small-Cell Lung Cancer
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1429
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
X. Liu
X. Lu
R. Guo
Publisher
Elsevier BV
Related search
Screening Circular RNAs Related to Acquired Gefitinib Resistance in Non-Small Cell Lung Cancer Cell Lines
Journal of Cancer
Oncology
Clinical Significance of Long Non-Coding RNA HOTTIP in Early-Stage Non-Small-Cell Lung Cancer
BMC Pulmonary Medicine
Pulmonary
Respiratory Medicine
Mechanism Research of miR‐34a Regulates Axl in Non‐small‐cell Lung Cancer With Gefitinib‐acquired Resistance
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
ERK Inhibition Represses Gefitinib Resistance in Non-Small Cell Lung Cancer Cells
Oncotarget
Oncology
BCYRN1, a C-Myc-Activated Long Non-Coding RNA, Regulates Cell Metastasis of Non-Small-Cell Lung Cancer
Cancer Cell International
Cancer Research
Oncology
Genetics
Long Non‑coding RNA NEAT1 Regulates E2F3 Expression by Competitively Binding to miR‑377 in Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
DDX17 Nucleocytoplasmic Shuttling Promotes Acquired Gefitinib Resistance in Non-Small Cell Lung Cancer Cells via Activation of Β-Catenin
Cancer Letters
Cancer Research
Oncology
Dysregulated Long Intergenic Non-Coding RNA Modules Contribute to Heart Failure
Oncotarget
Oncology
Overexpression of OCT4 Is Associated With Gefitinib Resistance in Non-Small Cell Lung Cancer
Oncotarget
Oncology